These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12045497)

  • 1. Decreased recovery of replication-competent HIV-1 from peripheral blood mononuclear cell-derived monocyte/macrophages of HIV-positive patients after 3 years on highly active antiretroviral therapy.
    Belmonte L; Baré P; Picchio GR; Perez Bianco R; de Tezanos Pinto M; Corti M; Villafañe MF; de Bracco MM; Ruibal-Ares BH
    AIDS; 2002 Jun; 16(9):1289-92. PubMed ID: 12045497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.
    Otero M; Nunnari G; Leto D; Sullivan J; Wang FX; Frank I; Xu Y; Patel C; Dornadula G; Kulkosky J; Pomerantz RJ
    AIDS Res Hum Retroviruses; 2003 Dec; 19(12):1097-103. PubMed ID: 14709246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.
    Zhu T; Muthui D; Holte S; Nickle D; Feng F; Brodie S; Hwangbo Y; Mullins JI; Corey L
    J Virol; 2002 Jan; 76(2):707-16. PubMed ID: 11752161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term decay of the HIV-1 reservoir in HIV-1-infected children treated with highly active antiretroviral therapy.
    Zanchetta M; Walker S; Burighel N; Bellanova D; Rampon O; Giaquinto C; De Rossi A
    J Infect Dis; 2006 Jun; 193(12):1718-27. PubMed ID: 16703516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication.
    Crowe SM; Sonza S
    J Leukoc Biol; 2000 Sep; 68(3):345-50. PubMed ID: 10985250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).
    Delaugerre C; Gourlain K; Tubiana R; Carcelain G; Marcelin AG; Chouquet C; Mouroux M; Duvivier C; Autran B; Costagliola D; Katlama C; Calvez V
    Antivir Ther; 2003 Jun; 8(3):233-7. PubMed ID: 12924540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 infection of monocytes is directly related to the success of HAART.
    Almodóvar S; Del C Colón M; Maldonado IM; Villafañe R; Abreu S; Meléndez I; Domínguez C; Cuevas W; Collins TM; Lorenzo E
    Virology; 2007 Dec; 369(1):35-46. PubMed ID: 17707072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of replication-competent HIV type 1-infected circulating monocytes from individuals receiving antiretroviral therapy.
    Harrold SM; Wang G; McMahon DK; Riddler SA; Mellors JW; Becker JT; Caldararo R; Reinhart TA; Achim CL; Wiley CA
    AIDS Res Hum Retroviruses; 2002 Apr; 18(6):427-34. PubMed ID: 11958686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain.
    Asahchop EL; Meziane O; Mamik MK; Chan WF; Branton WG; Resch L; Gill MJ; Haddad E; Guimond JV; Wainberg MA; Baker GB; Cohen EA; Power C
    Retrovirology; 2017 Oct; 14(1):47. PubMed ID: 29037245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections.
    Nunnari G; Otero M; Dornadula G; Vanella M; Zhang H; Frank I; Pomerantz RJ
    AIDS; 2002 Jan; 16(1):39-45. PubMed ID: 11741161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different resistance mutations can be detected simultaneously in the blood and the lung of HIV-1 infected individuals on antiretroviral therapy.
    White NC; Israel-Biet D; Coker RJ; Mitchell DM; Weber JN; Clarke JR
    J Med Virol; 2004 Mar; 72(3):352-7. PubMed ID: 14748057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells.
    Tsai WP; Conley SR; Kung HF; Garrity RR; Nara PL
    Virology; 1996 Dec; 226(2):205-16. PubMed ID: 8955040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy.
    Honeycutt JB; Thayer WO; Baker CE; Ribeiro RM; Lada SM; Cao Y; Cleary RA; Hudgens MG; Richman DD; Garcia JV
    Nat Med; 2017 May; 23(5):638-643. PubMed ID: 28414330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte differentiation and HIV replication after prolonged culture of peripheral blood mononuclear cells from HIV-infected individuals.
    Ruibal-Ares B; Belmonte L; Baré P; Bayo-Hanza C; Mendez G; Bianco RP; de Tezanos Pinto M; de Bracco MM
    Cell Immunol; 2001 May; 210(1):11-20. PubMed ID: 11485348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy.
    Lambotte O; Taoufik Y; de Goër MG; Wallon C; Goujard C; Delfraissy JF
    J Acquir Immune Defic Syndr; 2000 Feb; 23(2):114-9. PubMed ID: 10737425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.
    Dornadula G; Zhang H; VanUitert B; Stern J; Livornese L; Ingerman MJ; Witek J; Kedanis RJ; Natkin J; DeSimone J; Pomerantz RJ
    JAMA; 1999 Nov; 282(17):1627-32. PubMed ID: 10553788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Niubó J; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2012; 17(3):577-83. PubMed ID: 22301439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between HIV replication and cholesterol in peripheral blood mononuclear cells in HIV-infected patients interrupting HAART.
    Negredo E; Puigdomènech I; Marfil S; Puig J; Pérez-Alvarez N; Ruiz L; Rey-Joly C; Clotet B; Blanco J
    J Antimicrob Chemother; 2008 Feb; 61(2):400-4. PubMed ID: 18083750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of significant viral load alterations of hepatitis B virus and hepatitis C virus during treatment with IL-2 and highly active antiretroviral therapy.
    Hengge UR; Roggendorf M; Goos M
    AIDS; 2000 Nov; 14(16):2617-9. PubMed ID: 11101079
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation.
    Patro SC; Azzoni L; Joseph J; Fair MG; Sierra-Madero JG; Rassool MS; Sanne I; Montaner LJ
    J Leukoc Biol; 2016 Jul; 100(1):223-31. PubMed ID: 26609048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.